David Pyott, former CEO, Allergan, doesn’t mince words. He explains why he took such an aggressive stance against Valeant’s bid to buy his former company. Pyott also reveals the next stage in his career and answers the question, “Would he be a CEO again?”
David E.I. Pyott joined Allergan on January 1, 1998. During his tenure, Mr. Pyott has transformed Allergan from a small eye care business to a global specialty pharmaceutical and medical device company with leadership positions in six medical specialties.